1Pharmaceutical Research Department, Ciba-Geigy Limited, Basel, Switzerland.
Recombinant DNA technology created novel alpha-interferon (IFN-alpha) hybrids. These hybrids help study IFN-alpha structure-activity and interactions, leading to potential new therapeutics.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Failed At:
2026-06-19T13:40:52.575447+00:00